National Wilm's Tumor Study Late Effects

Not Applicable

Withdrawn

• Conditions: Wilm's Tumor
• Interventions: Other: none, screening only

• Registration Number: NCT00228696
• Lead Sponsor: Emory University

Brief Summary

The Late Effects Study is being conducted in order to answer scientific questions and to serve as a resource for Wilms tumor patients and their families. Patients must have been enrolled on the NWTS-5 protocol in order to be eligible for this study.

Detailed Description

The Late Effects Study is being conducted in order to answer scientific questions and to serve as a resource for Wilms tumor patients and their families. Although most people in this study enjoy good health, some may be at risk for certain health conditions. We are collecting information from as many participants as possible in order to determine if they or their offspring are at risk for adverse medical conditions. If there is more than one case of Wilms tumor in a given family, we plan to work with geneticists to try to estimate heritability and recurrence risks.

Study Timeline

• Study Start: 2005-09
• Study First Submitted: 2005-09-27
• Study First Submitted QC: 2005-09-27
• Study First Posted: 2005-09-29
• Primary Completion: 2010-12
• Study Completion: 2011-12
• Status Verified: 2013-11
• Last Update Submitted: 2013-11-23
• Last Update Posted: 2013-11-26

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Previously enrolled in NWTS 5.

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
screening	none, screening only	this is a screening study and no intervention.

Primary Outcome Measures

Name	Time	Method
To determine if survivors from Wilms tumors or their offspring are at risk for adverse medical conditions.	1 year after closure of study

Trial Locations

Locations (1)

Children's Healthcare of Atlanta; 🇺🇸 Atlanta, Georgia, United States